Sanz-Sánchez Jorge, Chiarito Mauro, Gill Gauravpal S, van der Heijden Liefke C, Piña Yigal, Cortese Bernardo, Alfonso Fernando, von Birgelen Clemens, Diez Gil Jose Luis, Waksman Ron, Garcia-Garcia Hector M
Hospital Universitari i Politecnic La Fe, Valencia, Spain.
Centro de Investigación Biomedica en Red (CIBERCV), Madrid, Spain.
J Soc Cardiovasc Angiogr Interv. 2022 Jul 11;1(5):100403. doi: 10.1016/j.jscai.2022.100403. eCollection 2022 Sep-Oct.
Small vessel coronary artery disease (CAD) is present in 30% to 67% of patients undergoing percutaneous coronary intervention according to different series, representing an unmet clinical need in light of an increased risk of technical failure, restenosis, and need for repeated revascularization. The definition of small vessel is inconsistent across trials, and no definite cutoff value has yet been determined. The lack of consensus on the definition of small vessel CAD has contributed to the high degree of heterogeneity in the safety and efficacy of the various revascularization options. Therefore, the aim of this article is to provide a critical appraisal of existing reports and to propose a reference vessel diameter of <2.5 mm definition of small vessel CAD to guide future clinical trials and clinical decision-making.
根据不同系列研究,在接受经皮冠状动脉介入治疗的患者中,30%至67%存在小血管冠状动脉疾病(CAD),鉴于技术失败、再狭窄风险增加以及需要重复血运重建,这代表了一种未满足的临床需求。各试验中小血管的定义不一致,尚未确定明确的临界值。小血管CAD定义缺乏共识导致了各种血运重建方案在安全性和有效性方面存在高度异质性。因此,本文的目的是对现有报告进行批判性评估,并提出将参考血管直径<2.5毫米作为小血管CAD的定义,以指导未来的临床试验和临床决策。